Fabio Ynoe de Moraes: The Power of Laser Focus - Lessons from Carlos Alcaraz

Fabio Ynoe de Moraes

Anu Agrawal: The 10th Global Health Catalyst Summit to Advance Global Cancer Collaboration

Anu Agrawal

ESGO President-Elect Jalid Sehouli's Message on World Gynecologic Oncology Day 2025

Jalid Sehouli

Douglas Flora: The Ultimate Two-Person Performance Review

Douglas Flora

Top 10 Oncogrants of the Week: Fueling the Next Wave of Cancer Research and Innovation

Top 10 Oncogrants of the Week: Fueling the Next Wave of Cancer Research and Innovation

More Than $358 Million Invested in Hope, Progress and Cures - Rally Foundation for Childhood Cancer Research

Childhood Cancer

Robin Zon: ASCO Launches ASCO Edge to Strengthen Practice Management and Patient Care

Robin Zon

Vincent Rajkumar: Key Takeaways From IMS25

Vincent Rajkumar, IMS25

OncoCalendar

« All Events

  • This event has passed.

Exploring a New Generation of Patient-Centric Cancer Clinical Trials by AACR

Jan 21 • 1:00 PM - 2:30 PM
AACR

Exploring a New Generation of Patient-Centric Cancer Clinical Trials by AACR will be held on January 21, 2025, Virtually.

The forum will explore the new generation of patient-centric cancer clinical trials, focusing on how advancements in cancer research will reshape the clinical trial process. As more people are expected to survive and live beyond cancer, largely due to clinical trials, the conference will highlight the ongoing transformation in trial design. The emphasis will be on creating more efficient, inclusive, and patient-focused trials that prioritize patient needs and preferences. This shift will be critical in ensuring broader access to innovative treatments and improving overall patient outcomes.

The upcoming session will feature a group of esteemed experts in the field of cancer research. Jan Tomlinson from the University of California, San Francisco, will share insights from a patient advocate’s perspective on the clinical trial experience. Patricia M. LoRusso, DO, PhD (HC), FAACR, from Yale Cancer Center, will discuss innovative clinical trial designs aimed at improving efficiency and inclusivity. David A. Tuveson, MD, PhD, FAACR, from CSHL Cancer Center, will highlight the Cancer Therapeutics Initiative, which focuses on translating basic research into clinical applications. Laura van ‘t Veer, PhD, from the University of California, San Francisco, will present on the second-generation design of the I-SPY 2 trial, driving advancements in precision medicine. These experts will cover a broad range of topics, all geared toward advancing cancer clinical trials and patient care.

Register Now!

Details

Date:
Jan 21
Time:
1:00 PM - 2:30 PM
Website:
https://www.aacr.org/patients-caregivers/patient-advocacy/aacr-events-for-patient-advocates/aacr-virtual-patient-advocate-forums/exploring-a-new-generation-of-patient-centric-cancer-clinical-trials/

Organizer

American Association for Cancer Research
Phone
215-440-9300
Email
aacr@aacr.org
View Organizer Website